POTELIGEO achieved greater ORR and longer DoR vs vorinostat1
ORR was based on global composite response score. Responses in blood and skin must have persisted for at least 4 weeks to be considered confirmed and were evaluated every 4 weeks for the first year. Responses in lymph nodes, in visceral disease, and overall were evaluated every 8 weeks for the first year.1
Median dose intensity was >95% for both treatment arms.3
aRepresents complete or partial best overall response rate. Best overall response was defined
as the best response from the start of treatment until disease progression/recurrence or end
of treatment.4
CR=complete response; PR=partial response REFERENCES +
Median dose intensity was >95% for both treatment arms.3
aRepresents complete or partial best overall response rate. Best overall response was defined
as the best response from the start of treatment until disease progression/recurrence or end
of treatment.4
CR=complete response; PR=partial response REFERENCES +